EarningsQ1 2026 Earnings Report

Santen Pharmaceutical Co (4536N) Q1 2026 Earnings Report

0 Followers

MX:4536N Q1 2026 EPS Results

Actual EPS$2.60

Consensus EPS$2.47

Beat/MissBeat by +$0.13

One Year Ago EPS$2.01

Actual Revenue$8.00B

Expected Revenue$8.16B

Beat/MissMissed by -$165.55M

YoY Revenue Growth+0.32%

QuarterQ1 2026

Date08/06/2026

TimeTBA

Conference CallThursday, August 6, 2026

MX:4536N Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:4536N Q1 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q2)	3.54 / -	2.835	―
Aug 06, 2026	2026 (Q1)	2.47 / 2.60	2.009	29.21% (+0.59)
May 12, 2026	2025 (Q4)	3.57 / 5.55	2.989	85.80% (+2.56)
Feb 05, 2026	2025 (Q3)	3.40 / 2.83	2.938	-3.67% (-0.11)
Nov 06, 2025	2025 (Q2)	2.42 / 2.84	2.702	4.94% (+0.13)
Aug 07, 2025	2025 (Q1)	2.77 / 2.01	3.433	-41.47% (-1.42)
May 13, 2025	2024 (Q4)	2.01 / 2.99	1.9	57.30% (+1.09)
Feb 06, 2025	2024 (Q3)	3.03 / 2.94	2.343	25.40% (+0.60)
Nov 07, 2024	2024 (Q2)	2.52 / 2.70	2.799	-3.48% (-0.10)
Aug 06, 2024	2024 (Q1)	3.01 / 3.43	3.24	5.94% (+0.19)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed